Search - tctmd.com

Displaying 541 - 560 of 895

Sort: Relevancy | Date

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Roman Tarasov

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Presenter: Tony Das, Thomas Zeller

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Debate: Culprit Only and Deferred Revascularization in STEMI Should Be Routine

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Guy Witberg

October 29, 2017

Presentation TCT 2017

Debate: Early Complete Revascularization in STEMI Should Be Routine

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Mahmoud Idris Traina

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Giulio G. Stefanini

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

Presentation TCT 2017

Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker

October 29, 2017

Presentation TCT 2017

Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Adrian P. Banning

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Qi Zhang

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Jian Liu

November 01, 2016

Presentation TCT 2016

TCT 1097: Successful Revascularization for Double-Vessel CTO

Presenter: M Chadi Alraies, Jose Armando Mangione, Dai-Yin Lu

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Advertisement

Live From Denver: TCT 2017, Day One

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Debate: Culprit Only and Deferred Revascularization in STEMI Should Be Routine

Debate: Early Complete Revascularization in STEMI Should Be Routine

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care

Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Case Conclusion: How Did I Treat?

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

TCT 1097: Successful Revascularization for Double-Vessel CTO

Case Introduction: How Should I Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content